Upon analyzing the tumor-infiltrating immune cells in the four treatment groups, we observed that the viable tumor-infiltrating immune cells (CD45+) were highly suppressed by the OXA treatment, presumably due to the general cytotoxicity of chemotherapy (Figs. 3A and S8). Here, PTPRC is linked to neoplasm.